2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Urinary Bladder Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Disease
2
Colorectal Neoplasms
2
Acute Kidney Injury
2
Tuberous Sclerosis
1
Spinal Cord Injuries
1
Smoldering Multiple Myeloma
1
Salivary Gland Adenoma, Pleomorphic
1
Renal Insufficiency
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Hemangiosarcoma
1
Glioma
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Dutasteride
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Transurethral Resection of Prostate
2
Therapeutics
2
Radiotherapy
2
Prostatectomy
2
Blood Specimen Collection
2
proxalutamide
1
polyphenon E
1
mirabegron
1
Urination
1
TroVax
1
Transurethral Resection of Bladder
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Psychiatric Rehabilitation
1
Prostate-Specific Antigen
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Magnetic Resonance Spectroscopy
1
Lycopene
1
Levofloxacin
1
Finasteride
1
Electroacupuncture
1
Doxazosin
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Hyperplasia
×
Urination
×
Clear all
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled